VIP and Headache: In a double-blind placebo-controlled crossover study, Hansen et al. evaluated twelve healthy subjects who received intravenous VIP or placebo over 25 min, which induced a very mild and short-lasting headache in five patients (42%) during VIP infusion compared to only one patient during placebo infusion [77].